NIH to cut billions from overheads in biomedical research

10 February 2025

In a statement on Friday, the USA’s National Institutes of Health (NIH) said it would cut grants for "indirect costs" related to research - such as buildings, utilities and equipment.

Some scientists believe the move will stifle scientific advancements, according to media reports, including for UK broadcaster the BBC.

"The United States should have the best medical research in the world," NIH said in its announcement, adding: "It is accordingly vital to ensure that as many funds as possible go towards direct scientific research costs rather than administrative overhead."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical